These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 36248878)

  • 1. HLA allele-specific expression: Methods, disease associations, and relevance in hematopoietic stem cell transplantation.
    Johansson T; Partanen J; Saavalainen P
    Front Immunol; 2022; 13():1007425. PubMed ID: 36248878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Implications of HLA in allogeneic stem cell transplantation].
    Morishima S
    Rinsho Ketsueki; 2019; 60(9):1324-1330. PubMed ID: 31597859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct HLA Genetic Comparisons Identify Highly Matched Unrelated Donor-Recipient Pairs with Improved Transplantation Outcome.
    Vazirabad I; Chhabra S; Nytes J; Mehra V; Narra RK; Szabo A; Jerkins JH; Dhakal B; Hari P; Anderson MW
    Biol Blood Marrow Transplant; 2019 May; 25(5):921-931. PubMed ID: 30537549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation.
    Sasazuki T; Inoko H; Morishima S; Morishima Y
    Adv Immunol; 2016; 129():175-249. PubMed ID: 26791860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of mismatched HLA on graft-versus-host disease in unrelated stem cell transplantation].
    Morishima S
    Rinsho Ketsueki; 2018; 59(8):1086-1094. PubMed ID: 30185710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept study.
    Han H; Yuan F; Sun Y; Liu J; Liu S; Luo Y; Liang F; Liu N; Long J; Zhao X; Kong F; Xi Y
    Oncotarget; 2015 Nov; 6(37):40337-59. PubMed ID: 26498683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leucocyte antigen diversity: A biological gift to escape infections, no longer a barrier for haploidentical Hemopoietic Stem Cell Transplantation.
    Andreani M; Gaspari S; Locatelli F
    Int J Immunogenet; 2020 Feb; 47(1):34-40. PubMed ID: 31657118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in genomic analysis of the human leukocyte antigen].
    Onizuka M
    Rinsho Ketsueki; 2019; 60(6):620-625. PubMed ID: 31281154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation.
    Tamouza R; Busson M; Rocha V; Fortier C; Haddad Y; Brun M; Boukouaci W; Bleux H; Socié G; Krishnamoorthy R; Toubert A; Gluckman E; Charron D
    Transplantation; 2006 Dec; 82(11):1436-40. PubMed ID: 17164714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved accuracy of clinical HLA genotyping by next-generation DNA sequencing affects unrelated donor search results for hematopoietic stem cell transplantation.
    Allen ES; Yang B; Garrett J; Ball ED; Maiers M; Morris GP
    Hum Immunol; 2018 Dec; 79(12):848-854. PubMed ID: 30316972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
    Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
    Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
    Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
    Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of HLA class II is associated with relapse after allogeneic stem cell transplantation and alters recognition by antigen-specific T cells.
    Adachi Y; Sakai T; Terakura S; Shiina T; Suzuki S; Hamana H; Kishi H; Sasazuki T; Arase H; Hanajiri R; Goto T; Nishida T; Murata M; Kiyoi H
    Int J Hematol; 2022 Mar; 115(3):371-381. PubMed ID: 35037229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which factors influence the development of GVHD in HLA-matched or mismatched transplants?
    Petersdorf EW
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):333-335. PubMed ID: 29156205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
    Greinix HT; Faé I; Schneider B; Rosenmayr A; Mitterschiffthaler A; Pelzmann B; Kalhs P; Lechner K; Mayr WR; Fischer GF
    Bone Marrow Transplant; 2005 Jan; 35(1):57-62. PubMed ID: 15531903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Outcome Analysis for HLA Loss Patients Following Partially Mismatched Related Donor Transplantation Using HLA Chimerism for Loss of Heterozygosity Analysis by Next-Generation Sequencing.
    Wang A; Li W; Zhao F; Zheng Z; Yang T; Wang S; Yan J; Lan J; Fan S; Zhao M; Shen J; Li X; Yang T; Lu Q; Lu Y; Bai H; Zhang H; Cai D; Wang L; Yuan Z; Jiang E; Zhou F; Song X
    Cell Transplant; 2022; 31():9636897221102902. PubMed ID: 35670196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of HLA in hematopoietic SCT.
    Nowak J
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S71-6. PubMed ID: 18978750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen disparities reduce relapse after hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: A single-center retrospective study from China.
    Lin YC; Luo CJ; Miao Y; Wang JM; Luo CY; Qin X; Cai JY; Li BS; Chen J
    Pediatr Transplant; 2021 Mar; 25(2):e13825. PubMed ID: 33131184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated With Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival.
    Kordelas L; Schwich E; Lindemann M; Heinemann FM; Buttkereit U; Horn PA; Beelen DW; Rebmann V
    Front Immunol; 2019; 10():3027. PubMed ID: 31998310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.